News|Articles|January 23, 2024
Inhaled Biologics from Zero
Author(s)Experic
Experic’s latest article looks at new initiatives aimed at fostering the development of biologics delivered via inhalation, an emerging field. While manufacturing technologies have advanced to support this sector, several challenges remain, including an unclear regulatory pathway.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Trends and Challenges Impacting Highly Potent API Development
2
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
3
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
4
How Innovation and Risk Management Are Reshaping Modern Drug Manufacturing
5
